Dengue’s Clinical Course in One of Colombia’s Most Endemic Areas: Impact of Endemic and Epidemic Periods
The American Journal of Tropical Medicine and Hygiene · 2026
DOI: 10.4269/ajtmh.25-0158 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2026. Verfasst von Gisel Viviana Osorio-Cuéllar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Center, Clínica Imbanaco, Cali, Colombia. Hauptthemen laut MEDLINE: Dengue, Endemic Diseases, Epidemics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Dengue is a viral disease with a broad spectrum of clinical manifestations. Its severity is associated with risk factors such as periods of endemicity, although the extent of this contribution is unclear. In the present study, the characteristics of the clinical course and differences in the occurrence of severe and lethal outcomes were assessed by the degree of endemicity in patients with dengue treated in health institutions in Cali, Colombia, between 2019 and 2022. A longitudinal, observational-historical, single-cohort study was conducted. Analysis involved evaluating clinical complications during epidemic and endemic periods. Mortality, cumulative incidence of hospital or intensive care unit (ICU) admission, and survival time were estimated using the competing risks method. A total of 1,038 dengue cases were included. Patients with severe dengue and those with warning signs (WS) were consulted up to 6 or 5 days after symptom onset, respectively. A hospital stay of 2.0 days (Quartile [Q]1–Q3: 2–4 days) and an ICU stay of 4.5 days (SD ± 3.9 days) were estimated. A mortality rate of 5.5% was obtained for severe dengue, and a mortality rate of 0.4% was identified for patients with WS. In 2020 and 2021, the probability of hospitalization was 20% from initial contact. The likelihood of dying within 10 days after initial contact was 0% in 2019 and 11.2% (95% CI: 4.0–22.5%) in 2020. The incidence of hospitalization, number of hospital days, and ICU stays due to dengue varied by epidemiological year in a high-endemicity area. The probability of severe and lethal clinical outcomes was higher during 2020 and 2021.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Research Center, Clínica Imbanaco, Cali, Colombia.
- Population Health, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
- Takeda Colombia, Bogotá, Colombia.
- Universidad del Bosque, Bogotá, Colombia.
- Cafettor Médica S.A.S, Bogotá, Colombia.
- Hospital Universitario Evaristo García E.S.E, Cali, Colombia.
Zitieren
APA
Osorio-Cuéllar, G. V., Quintero, J., Gaitan, A. A., Torres-Martínez, C., Daza, M., Clemen, G., Muñoz Garzón, L. E., Oñate, J., Bernal-Sanchez, M., & Cañón Muñoz, M. (2026). Dengue’s Clinical Course in One of Colombia’s Most Endemic Areas: Impact of Endemic and Epidemic Periods. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.25-0158
Vancouver
Osorio-Cuéllar GV, Quintero J, Gaitan AA, Torres-Martínez C, Daza M, Clemen G, et al. Dengue’s Clinical Course in One of Colombia’s Most Endemic Areas: Impact of Endemic and Epidemic Periods. The American Journal of Tropical Medicine and Hygiene. 2026. doi:10.4269/ajtmh.25-0158
BibTeX
@article{OsorioCullar2026,
author = {Osorio-Cuéllar, Gisel Viviana and Quintero, Juliana and Gaitan, Alvaro Andres and Torres-Martínez, Carlos and Daza, Marcela and Clemen, Gustavo and Muñoz Garzón, Luz Elena and Oñate, José and Bernal-Sanchez, Mauricio and Cañón Muñoz, Martín},
title = {Dengue’s Clinical Course in One of Colombia’s Most Endemic Areas: Impact of Endemic and Epidemic Periods},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2026},
doi = {10.4269/ajtmh.25-0158}
}
EUVIMED